The purpose of this study is to observe or not a reduction on pain and anxiety felt by the patient when performing an ultrasound-controlled ankle block in preparation for forefoot surgery, using a virtual reality device instead of drug sedation.
Currently, in preparation for forefoot surgery, the realization of the ankle block is accompanied by drug sedation. The investigator's randomized study aims to compare the anxiety and pain experienced by patients who have benefited from drug sedation with those of patients who benefited from the virtual reality device at the time of the realization of the ankle block.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
The patient will have the choice between different environments and the use of this device will remain under the control of the medical team. The patient will wear the virtual reality device at the time of the completion of the ankle block and will remove it once the nerve puncture is complete.
Venous administration of 1.25 mg of Droleptan
Venous administration of 20 mg of Propofol
Clinique Saint Jean
Montpellier, France
Digital visual scale to assess pain of patients during the treatment
Numeric scale numbered from 0 to 10. 0: no pain 10 : worst possible pain
Time frame: 5 min after the first nerve punction
Digital visual scale to assess anxiety of patients during the treatment
Numeric scale numbered from 0 to 10. 0: no anxiety 10 : worst possible anxiety
Time frame: 5 min after the first nerve punction
Patient satisfaction questionnaire
Concerns all patients Numeric scale numbered from 0 to 10. 0: unsatisfied 10 : very satisfied
Time frame: 5 min after the last nerve punction
Patient comfort assessment questionnaire
Concerns all patients. This is a question to determine their comfort levels during the experiment. Numeric scale numbered from 1 to 5. 1. : very comfortable 2. : comfortable 3. : less comfortable 4. : uncomfortable 5. : very uncomfortable
Time frame: 5 min after the last nerve punction
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Venous administration of 5 μg of Sufentanyl.